L Cova
Overview
Explore the profile of L Cova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mauri G, Cova L, Tondolo T, Ierace T, Baroli A, Di Mauro E, et al.
J Clin Endocrinol Metab
. 2013 May;
98(7):E1203-7.
PMID: 23666969
Context: Percutaneous laser ablation (PLA) may be useful in treating patients with metachronous metastatic lymph nodes in the neck. Objective: Our objective was to assess PLA as a treatment of...
2.
Saade F, Buronfosse T, Guerret S, Pradat P, Chevallier M, Zoulim F, et al.
J Viral Hepat
. 2013 Mar;
20(4):e56-65.
PMID: 23490390
DNA-based vaccination appears of promise for chronic hepatitis B immunotherapy, although there is an urgent need to increase its efficacy. In this preclinical study, we evaluated the therapeutic benefit of...
3.
Calzarossa C, Bossolasco P, Besana A, Manca M, De Grada L, De Coppi P, et al.
Neuroscience
. 2013 Jan;
234:158-72.
PMID: 23291343
The capability to integrate into degenerative environment, release neurotrophic cytokines, contrast oxidative stress and an inherent differentiation potential towards siteappropriate phenotypes are considered crucial for the use of stem cells...
4.
Bossolasco P, Cova L, Levandis G, Diana V, Cerri S, Lambertenghi Deliliers G, et al.
Int J Nanomedicine
. 2012 Feb;
7:435-47.
PMID: 22334776
Background: We have previously shown that human mesenchymal stem cells (hMSCs) can reduce toxin-induced neurodegeneration in a well characterized rodent model of Parkinson's disease. However, the precise mechanisms, optimal cell...
5.
Bigini P, Veglianese P, Andriolo G, Cova L, Grignaschi G, Caron I, et al.
Rejuvenation Res
. 2011 Oct;
14(6):623-39.
PMID: 21978082
The lack of effective drug therapies for motor neuron diseases (MND), and in general for all the neurodegenerative disorders, has increased the interest toward the potential use of stem cells....
6.
Silani V, Calzarossa C, Cova L, Ticozzi N
CNS Neurol Disord Drug Targets
. 2010 Apr;
9(3):314-24.
PMID: 20406179
Given the lack of effective drug treatments for amyotrophic lateral sclerosis (ALS), compelling preclinical data on stem cell research has targeted this disease as a candidate for stem cell treatment....
7.
Bossolasco P, Cova L, Calzarossa C, Rimoldi S, Borsotti C, Lambertenghi Deliliers G, et al.
Exp Neurol
. 2005 May;
193(2):312-25.
PMID: 15869934
Bone marrow (BM) is a rich source of stem cells and may represent a valid alternative to neural or embryonic cells in replacing autologous damaged tissues for neurodegenerative diseases. The...
8.
Solbiati L, Ierace T, Tonolini M, Cova L
Eur Radiol
. 2004 Mar;
13 Suppl 3:N87-90.
PMID: 15015887
No abstract available.
9.
Thermet A, Robaczewska M, Rollier C, Hantz O, Trepo C, Deleage G, et al.
J Virol
. 2004 Jan;
78(4):1945-53.
PMID: 14747559
The induction of humoral response in ducks by DNA-based immunization against duck hepatitis B virus (DHBV) core protein (DHBc) was investigated. In addition, the amino acid specificity of the induced...
10.
Solbiati L, Tonolini M, Cova L, Goldberg S
Eur Radiol
. 2002 Jan;
11 Suppl 3:E15-26.
PMID: 11793049
No abstract available.